Synchrony Financial Gets a Buy Rating from BMO Capital

By Carrie Williams

In a report released yesterday, James Fotheringham from BMO Capital reiterated a Buy rating on Synchrony Financial (NYSE: SYF), with a price target of $38. The company’s shares closed yesterday at $26.85.

According to, Fotheringham is a 5-star analyst with an average return of 9.8% and a 68.3% success rate. Fotheringham covers the Financial sector, focusing on stocks such as Discover Financial Services, Goldman Sachs Group Inc, and Apollo Investment Corp.

Currently, the analyst consensus on Synchrony Financial is Moderate Buy and the average price target is $36.71, representing a 36.7% upside.

In a report issued on May 19, Wells Fargo also maintained a Buy rating on the stock with a $30 price target.

The company has a one year high of $38.06 and a one year low of $23.25. Currently, Synchrony Financial has an average volume of 8.77M.

Based on the recent corporate insider activity of 72 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of SYF in relation to earlier this year. Last month, Jeffrey Naylor, a Director at SYF bought 7,000 shares for a total of $193,340.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Synchrony Financial operates as a holding company, which engages in the provision of consumer financial services. It operates through three sales platforms: Retail Card, Payment Solutions, and CareCredit. The Retail Card platform is a provider of private label credit cards, and also provides Dual Cards and small-and medium-sized business credit products. The Payment Solutions platform is a provider of promotional financing for major consumer purchases, offering private label credit cards and installment loans. The CareCredit platform is a provider of promotional financing to consumers for elective healthcare procedures or services, such as dental, veterinary, cosmetic, vision and audiology. The company was founded on September 12, 2003 and is headquartered in Stamford, CT.